Home › Clinically Validated NGS Assays Miss Challenging But Important Variants, Study Finds

Clinically Validated NGS Assays Miss Challenging But Important Variants, Study Finds

Apr 13, 2018

CHARLOTTE, NC (GenomeWeb) — Laboratories with clinically validated next-gen sequencing assays are having trouble detecting certain complex variants, according to a recent interlaboratory study led by researchers at Invitae, suggesting that better standards are needed to ensure the quality of NGS-based genetic testing.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oct
02
Featured Webinar

Utilization of Multiple Molecular Testing Methodologies to Aid in Lung Cancer Patient Management

In the last few years several molecular testing methodologies — such as immunohistochemistry, PCR, and sequencing — have been approved by the US Food and Drug Administration to aid in the management of patients with lung cancer.  

Oct
04
Featured Webinar

Software Tools for NGS-Based Diagnosis of CFTR-Related Diseases in Routine Practice

This webinar will discuss the use of new software tools to support the diagnosis of CTFR-related disorders using next-generation sequencing.

Oct
10
Featured Webinar

Personalization of Oncology Pathways: Clinical Quality Initiatives Amid a Complex Molecular Landscape

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.

Oct
23
Featured Webinar

Perspectives on Small RNA Sequencing: Challenges and Complications of Small RNA Library Prep

Sponsored by
PerkinElmer

This webinar will address a range of methods for optimizing small RNA library preparation.

What's Popular?

In Molecular Diagnostics

  1. Canon Medical Systems Acquires Majority Stake in Cancer Genomic Profiling JV

  2. Premaitha Licenses NIPT Tech From Illumina Under Settlement

  3. India's MolBio Brings Tuberculosis MDx to Point of Care With Help From FIND

    Premium

  4. Cepheid Fingerstick HCV Test Receives CE-IVD Clearance

  5. Biocept Plans to Sell $2.5M in Stock, Warrants

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.